𝔖 Bobbio Scriptorium
✦   LIBER   ✦

siRNA gelsolin knockdown induces epithelial-mesenchymal transition with a cadherin switch in human mammary epithelial cells

✍ Scribed by Hiroki Tanaka; Reza Shirkoohi; Koji Nakagawa; Hongjiang Qiao; Hisakazu Fujita; Futoshi Okada; Jun-ichi Hamada; Satoshi Kuzumaki; Masato Takimoto; Noboru Kuzumaki


Publisher
John Wiley and Sons
Year
2006
Tongue
French
Weight
718 KB
Volume
118
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Epithelial‐mesenchymal transition (EMT) describes a process occurring during development and oncogenesis by which epithelial cells obtain fibroblast‐like properties and show reduced cell adhesion and increased motility. In this report, we demonstrated typical EMT in human mammary epithelial MCF10A small interfering (si)RNA gelsolin‐knockdown cells. EMT was characterized by fibroblastic morphology, loss of contact inhibition and focus formation in monolayer growth, enhanced motility and invasiveness in vitro, increased actin filaments, overexpression of RAC, activation of both extracellular signal‐regulated kinase and AKT, inactivation of glycogen synthase kinase‐3, conversion of cadherin from the E‐ to N‐type and induction of the transcription factor Snail. These results suggested that gelsolin functions as a switch that controls E‐ and N‐cadherin conversion via Snail, and demonstrated that its knockdown leads to EMT in human mammary epithelial cells and possibly to the development of human mammary tumors. © 2005 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Resistance to taxanes is induced by c-er
✍ Fortunato Ciardiello; Rosa Caputo; Grazia Pomatico; Michelino De Laurentiis; Sab 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 122 KB

We have tested the sensitivity of human MCF-10A mammary epithelial cells and of their transformed derivatives overexpressing an activated c-Ha-ras gene (MCF-10A Ha-ras cells), the c-erbB-2 gene (MCF-10A c-erbB-2 cells) or both genes (MCF-10A HE cells) to different cytotoxic drugs. As compared with p